Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting ...

(39:11)

What is cereblon? #myeloma

(42)

Cereblon modulators: a new class of myeloma therapy — Dr. Sagar Lonial | MCRT Webcast August 22

(12:22)

What is cereblon and how is it related to IMiDs? #myeloma

(3:16)

What is a CELMoD?

(2:25)

Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Ot...

(39:11)

Cereblon (CRBN), Common Target of Multiple Pharmacological Actions of Thalidomide and Derivatives

(40:18)

Optimising the management of multiple myeloma in the early relapsed/refractory setting

(1:16:23)

Cereblon enhancer methylation and IMiD resistance in multiple myeloma

(2:13:)

The rationale for protein degradation and immunomodulation in RRMM: Latest data and clinical trials

(32:14)

Highlights- Optimising the management of multiple myeloma in the early relapsed refractory setting

(5:26)

Next-Generation Drugs Targeting the Cereblon Ubiquitin Ligase

(2:7)

Genomic Studies to Identify Mechanisms of Resistance to IMiDs Drugs in Multiple Myeloma

(7:8)

Dr. Biran Discusses a Selinexor Triplet for RRMM

(4:29)

What are IMiDs and how do they work?

(4:15)

Treatment Talk: IMiDs

(2:6)

Benefits of CELMoDs over IMiDs in multiple myeloma

(2:31)

Making Revolutionary Treatments Mundane | Boston RT Sept 16, 2023

(25:39)

What is a CELMoD? How is it different from and IMiD? #myeloma

(5:43)

Immunomodulatory Drugs and DDB1-CRBN E3 Ubiquitin Ligase in virtual reality

(10:13)